Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia, Myeloid, Acute

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

2,461 public trials 543 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Completed

A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies

NCT02038777

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hematologic Neoplasms, +7 more
Locations: Japanese Red Cross Nagoya First Hospital Nagoya, Aichi-ken, Japan

Kobe University Hospital Kobe, Hyōgo, Japan

Tohoku University Hospital Sendai, Miyagi, Japan

Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital Bunkyo-ku, Tokyo, Japan

View Trial Details

Completed

IDH1/2 Mutational Analysis in AML Patients: Diagnosis and Follow-up

NCT04242849

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy

NCT03839446

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

WT1 for the Detection of Minimal Residual Disease

NCT00179829

Conditions: Bone Marrow Diseases, Cancer, Chronic Disease, +18 more
Locations: Ann & Robert H Lurie Children's Hospital of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Study of Allogeneic Double Negative T Cells (DNT-UHN-1) in Patients With High Risk Acute Myeloid Leukemia

NCT03027102

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Completed

A Study to Investigate 14C-bemcentinib in Healthy Male Subjects

NCT06469138

Conditions: Acute Myeloid Leukemia, Adenoma, Astrocytoma, +55 more
Locations: Labcorp Clinical Research Unit Ltd. Leeds, United Kingdom

View Trial Details

Completed

GITMO AML/MDS-Relapse Registry Study

NCT06790680

Conditions: Acute Myeloid Leukaemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: GITMO Bologna, Italy

View Trial Details

Completed

BI 836858 Dose Escalation in Patients With Refractory or Relapsed Acute Myeloid Leukemia and in Patients With AML in Complete Remission With High Risk to Relapse

NCT01690624

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations: Northwestern University Chicago, Illinois, United States

Johns Hopkins Hospital Baltimore, Maryland, United States

Washington University School of Medicine St Louis, Missouri, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

NCT03154190

Conditions: Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +146 more
Locations: Virginia K Crosson Cancer Center Fullerton, California, United States

View Trial Details

Completed

A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)

NCT02997202

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Mayo Clinic Phoenix, Arizona, United States

Virginia G Piper Cancer Center Scottsdale, Arizona, United States

University of California San Francisco San Francisco, California, United States

View all 118 locations

View Trial Details